Important Safety Information:
Contraindicated for children under 6 years of age, nursing mothers, patients with severe hypertension, severe coronary artery disease, and in patients receiving MAO inhibitor therapy, or those with hypersensitivity to any of the ingredients. Considerable caution should be used when prescribing Zinx™ GCP to patients with hypertension, diabetes mellitus, ischemic heart disease, hyperthyroidism, increased intraocular pressure, and prostatic hypertrophy. Sympathomimetic amines may produce central nervous system stimulation with convulsions or cardiovascular collapse with accompanying hypotension. The elderly are more likely to exhibit adverse reactions to sympathomimetic amines. Zinx™ GCP may cause excitability, particularly in children. Patients should also be advised to consult a physician immediately if their cough persists for more than one week, tends to recur, or is accompanied by a high fever, rash or persistent headache. See package insert for full prescribing information. The most common side effects when taking Zinx™ Lozenges are bad aftertaste and irritation of the mouth. In clinical trials, mouth dryness and constipation were also noted. See Drug Facts for full information on Zinx™ Lozenges.
|